FJX1 and nasopharyngeal carcinoma: Having shown that FJX1 peptides can be recognized by inherent T-cells from healthy donors and NPC patients, we next sought to assess if the peptides are able to enhance T-cell immune response and target recognition after presented by antigen presenting DCs.